Alumis ALMS
NASDAQ ALMS
$6.81 +0.11 (+1.64%)
As of: Oct 21, 2026 · 12:56 PM EDT

Alumis (ALMS) Receivables (2025)

Updated

Alumis (ALMS) reported Receivables of $100,000 for Q4 2025, unchanged from the prior quarter.

Analysis

Alumis (ALMS) Receivables (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn 13.82 Bn
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn 15.68 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn 12.49 Bn
10 Alumis 870.91 Mn -803.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 2.70 Mn
API Access

Alumis Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ALMS&period=max&api_key=YOUR_API_KEY